Moving Clinical Operations Forward During Pandemic

In this ISSUE

FDA Promotes More Diversity in Clinical Trials

The Beginning of the End of Clinical Trials As We Know Them?

Trial Sites

The Effect of COVID-19 on Clinical Trials: Insights from the Inside

Findings from a survey of 363 clinical trial sites showing the profound effect of the coronavirus pandemic.
... /Read more/

Decentralized Trials

The New Dinosaur: Sponsors Who Do Not Decentralize Their Studies

Companies that have piloted decentralized workflows are benefiting from technologies that support study operations in the disruption caused by COVID-19, but how will the rest survive the new norm?
... /Read more/

Regulatory Affairs

More Coordination Sought for Exploding COVID-19 R&D Efforts

With hundreds of clinical trials for potential coronavirus therapies in the works, concerns have mounted about the emergence of conflicting data, useless results, and wasted efforts from multiple overlapping efforts.
... /Read more/

EMA Wins Points for Its COVID-19 Responsiveness

Europe may not be yet be winning huge praise for its response to the COVID-19 pandemic—but the EMA is coming out of it with flying colors.
... /Read more/

Q&A

The Need for Virtual Trials: A Site’s Perspective

Vivienne van de Walle, co-founder and owner of PT&R, discusses the impact COVID-19 has had on her site, clinical research as a whole and the need for virtual trials.
... /Read more/

Calendar

/ DIA 2020 Global Annual Meeting — 6/14-6/18 /

/ Rare Disease Innovation and Partnering Summit — 6/24-6/26 /

Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com

Advertise

Todd Baker
Group Publisher
tbaker@mmhgroup.com

Bioforum, the Forum for EmergingBio's Outsourcing Decisions
As the biopharma industry traverses unchartered waters amid the COVID-19 crisis and doubles down on its efforts to bring new therapies to market faster, cheaper and without affecting quality, the success of strategic partnerships and functional service provider models will become more critical than ever before.
Read the article

website / blog / advertise / subscribe